CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF,
Frankfurt: 6PH) (the “
Company” or
“
CloudMD”), a healthcare technology company
transforming the delivery of care, is pleased to announce that
through its subsidiary, IDYA4 LLC., it has received U.S. Patent
Approval for its Real Time Intervention Platform
(“
RTIP”) which is the technology backbone for
CloudMD’s comprehensive healthcare platform that addresses all
points of a patients care from one, connected platform. Given the
continued rapid growth of the Company, receiving patent approval is
both timely and very important for CloudMD, as it protects its
proprietary intellectual property.
This technology connects and integrates the
Company’s capabilities and supports a data exchange across primary
care, mental health, specialists, rehabilitation, occupational
health, and education, providing a holistic approach to managing
the health and wellness of individuals.
CloudMD is targeting the employer market with
its comprehensive healthcare platform and has already onboarded
over 260,000 individuals who are receiving customized health plans.
A key component of this technology is the ability to report data,
analytics and outcomes to measure the success of programs securely
with all the required privacy controls. This connected approach to
care is already receiving positive outcomes with a net promoter
score of 78% and results where 91% of reassessed individuals with
depression showing improvement and 89% of reassessed individuals
with anxiety showing symptom improvement.
Dr. Essam Hamza, CEO of CloudMD
commented, “Receiving this patent now is both extremely critical
and timely as it safeguards our proprietary technology, which is
core to our integrated healthcare platform. The RTIP technology
connects all our different capabilities and shares valuable data in
real-time. We have already seen significant growth across the
United States as various modules of our platform are being rolled
out to support a number of key health and wellness programs. As a
key part of our expansion strategy, we will continue to roll out
these programs across North America.”
Karen Adams, President of
CloudMD commented, “The RTIP platform will support
CloudMD’s data warehouse infrastructure making it capable of
receiving, transforming and storing personal health data from care
plans, provider-based electronic medical records, health profiles,
health apps, wearables, devices, and benefit providers. This
infrastructure will drive further insights and recommendations to
personalize care, in real time, for providers and users.
Traditional healthcare systems and programs are siloed and hard to
navigate. CloudMD’s proprietary platform delivers connected,
holistic care resulting in better access to care and improved
health outcomes. The RTIP technology is the cornerstone to our
comprehensive health services platform, and we believe that this
technology is a key differentiator in confidentially being able to
connect users, analyze data and ensure effective health
outcomes.”
The RTIP platform’s patent is a testament to its
purposeful ability to deliver real-time health data integration in
a secure manner. The platform has been tested and continues to be
used by the U.S. Department of Justice, U.S. Department of Health
and Human Services as well by various other government agencies at
the federal, state and local level. The RTIP platform has multiple
use cases within the U.S. including, but not limited to, law
enforcement health and wellness, substance use disorder programs
and in the realm of opioid addiction.
Within the law enforcement community, the RTIP
platform is the foundation of the integrated platform and is being
used to provide access to health and wellness resources and support
to the law enforcement community. Individuals can access the
platform and resources from one point within their own private
environment without compromising their privacy and data
security. This platform is being used widely across various
states and counties and currently 1,500 law enforcement officials
have access.
The RTIP platform is also being used to identify
and eliminate overdose deaths due to substance use
disorders. This program has already been onboarded by a county
in New Jersey and additional funding has been received to expand
the program to additional counties within the state. CloudMD has
built a scalable platform and is focused on creating a national
model that can be expanded to support additional states across the
U.S.
The RTIP platform is also being used to support
the national opioid crisis, connecting public health, social
services, and public safety systems to address the real time needs
of the individuals who have overdosed or may be at risk. This
program funded by the U.S. Department of Justice and a local public
safety agency and is already operational in New Jersey. CloudMD has
been awarded an additional contract by the State of Nebraska to
assist in the modernization of Health and Human Service systems for
the state. The contract covers a six year period and CloudMD
is one of the five companies that has been collaboratively awarded
the contract.
About CloudMD Software & Services
CloudMD is transforming the delivery of
healthcare using technology and by providing a patient-centric
approach, with an emphasis on continuity of care. By leveraging
healthcare technology, the Company is building one, connected
platform that addresses all points of a patient’s healthcare
journey and provides better access to care and improved outcomes.
Through CloudMD’s proprietary technology, the Company delivers
quality healthcare through a holistic offering including hybrid
primary care clinics, specialist care, telemedicine, mental health
support, healthcare navigation, educational resources and
artificial intelligence (AI). CloudMD’s Enterprise Health Solutions
Division includes one of the top 4 Employee Assistance Programs in
Canada and offers one comprehensive, digitally connected platform
for corporations, insurers and advisors to better manage the health
and wellness of their employees and customers.
CloudMD currently services a combined ecosystem
of over 7,000 psychiatrists, approximately 4,500 therapists and
counsellors, approximately 4,000 psychologists, over 22,000 family
physicians, over 34,000 medical specialists, over 1,500 allied
health professionals across North America. For more information
visit: https://investors.cloudmd.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
“Dr. Essam Hamza, MD"Chief Executive Officer
FOR ADDITIONAL INFORMATION, CONTACT:
Julia BeckerVP, Investor
Relations julia@cloudmd.ca(604) 785-0850
Forward Looking Statements
This news release contains forward-looking
statements that are based on CloudMD’s expectations, estimates and
projections regarding its business and the economic environment in
which it operates, including with respect to its business plans.
Although CloudMD believes the expectations expressed in such
forward-looking statements are based on reasonable assumptions,
such statements are not guarantees of future performance and
involve risks and uncertainties that are difficult to control or
predict. Therefore, actual outcomes and results may differ
materially from those expressed in these forward-looking statements
and readers should not place undue reliance on such statements.
These forward-looking statements speak only as of the date on which
they are made, and CloudMD undertakes no obligation to update them
publicly to reflect new information or the occurrence of future
events or circumstances, unless otherwise required to do so by
law.
The TSX Venture Exchange does not accept
responsibility for the adequacy or accuracy of this release.
CloudMD Software & Servi... (TSXV:DOC)
Historical Stock Chart
From Mar 2024 to Apr 2024
CloudMD Software & Servi... (TSXV:DOC)
Historical Stock Chart
From Apr 2023 to Apr 2024